http://healthcare-economist.com/2006/04/29/802m/ An unbiased look at today's health care issues Thu, 20 Nov 2008 14:57:22 +0000 http://wordpress.org/?v=2.6.3 http://healthcare-economist.com/2006/04/29/802m/#comment-178246 Wikipedia says there’s no known treatment for Alopecia Areata, is that right? - Hair Loss Awareness, Alopecia, General Hair Loss, Fri, 07 Nov 2008 11:24:08 +0000 http://healthcare-economist.com/2006/04/29/802m/#comment-178246 [...] to this article it takes on average 90.3 months and $802 million (2005) to get a drug through FDA approval, so [...] [...] to this article it takes on average 90.3 months and $802 million (2005) to get a drug through FDA approval, so [...]

]]> http://healthcare-economist.com/2006/04/29/802m/#comment-164666 Random Dispatches » Blog Archive » Rolling The Dice Sat, 26 Jul 2008 15:07:15 +0000 http://healthcare-economist.com/2006/04/29/802m/#comment-164666 [...]  It’s a tough process as it takes, on average, 90 months (that’s 7 years!) and $802 million to get a drug to market (that includes the cost of all the failed [...] [...]  It’s a tough process as it takes, on average, 90 months (that’s 7 years!) and $802 million to get a drug to market (that includes the cost of all the failed [...]

]]> http://healthcare-economist.com/2006/04/29/802m/#comment-137449 Barack’s Trustafarians | The GOPNation Blog Tue, 11 Mar 2008 12:34:24 +0000 http://healthcare-economist.com/2006/04/29/802m/#comment-137449 [...] for lowering pharmaceutical profits; although, he remains alarmingly silent in regards to the $802 million it costs Big Pharma to get their products to pass DEA [...] [...] for lowering pharmaceutical profits; although, he remains alarmingly silent in regards to the $802 million it costs Big Pharma to get their products to pass DEA [...]

]]> http://healthcare-economist.com/2006/04/29/802m/#comment-96944 A possible cancer cure? - Online Debate Network Forums Wed, 31 Oct 2007 01:18:43 +0000 http://healthcare-economist.com/2006/04/29/802m/#comment-96944 [...] Costs are now up around a billion dollars or more and you've just tacked on several more years. Healthcare Economist · Cost to bring drug to market: $802m Now only about 1/5 of all drugs that make it to phase I clinical trials are ever going to get [...] [...] Costs are now up around a billion dollars or more and you’ve just tacked on several more years. Healthcare Economist · Cost to bring drug to market: $802m Now only about 1/5 of all drugs that make it to phase I clinical trials are ever going to get [...]

]]> http://healthcare-economist.com/2006/04/29/802m/#comment-82 Healthcare Economist · Corruption in the FDA Wed, 03 May 2006 16:52:51 +0000 http://healthcare-economist.com/2006/04/29/802m/#comment-82 [...] Pharmaceutical companies spent hundreds of millions of dollars in order to gain FDA approval for their products. A biologist at the FDA headquarters makes between $38 and $86 thousand.  The diffeence between these two sums is emormous; thus, it would not be surprising if the FDA was ripe with corruption. [...] [...] Pharmaceutical companies spent hundreds of millions of dollars in order to gain FDA approval for their products. A biologist at the FDA headquarters makes between $38 and $86 thousand.  The diffeence between these two sums is emormous; thus, it would not be surprising if the FDA was ripe with corruption. [...]

]]>